Legend Biotech Corporation
LEGNNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $3.95B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $16.24$37.50
- Volume (live)
- -
- Avg. volume (3M)
- 2.15M
Legend Biotech (LEGN) Stock Price & Financial Analysis
Legend Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $19.08 - $21.04 |
|---|---|
| 52-Week High | $37.50 |
| 52-Week Low | $16.24 |
| Open | $19.17 |
| Volume (last close) | 2.37M |
| Average Volume (3M) | 2.15M |
| Revenue (TTM) | 1.27B |
|---|---|
| Net Income (TTM) | -91.60M |
| Free Cash Flow (TTM) | -140.53M |
| EPS (TTM) | −$0.49 |
| Profit Margin | -7.21% |
| Operating Margin | -4.42% |
| Return on Equity (ROE) | -7.45% |
| Debt to Equity | 0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 3.95B |
|---|---|
| Shares Outstanding | 193.80M |
| Price to Sales (P/S) | 3.11 |
| Price to Book (P/B) | 3.21 |
| EV/EBITDA | -576.95 |
| 50-Day MA | $19.64 |
|---|---|
| 200-Day MA | $22.21 |
| 1-Year Change | −40.32% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Legend Biotech at a Glance
As of the Oct 26, 2026 close, Legend Biotech (LEGN) has a market capitalization of $3.95B. The stock trades at 3.1× sales. Over the trailing twelve months it lost $91.60M on revenue of $1.27B and burned $140.53M of free cash flow. Revenue grew 59.5% year over year.
As of its latest reported balance sheet, it holds $672.90M in cash and securities against $266.40M of debt, a net cash position of $406.50M.
Legend Biotech does not currently pay a dividend.
The share price is down 40.3% over the past year. At $20.39 (the Oct 26, 2026 close) it sits within its 52-week range of $16.24 to $37.50, below its 200-day moving average of $22.21.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $44.01, 115.8% above the Oct 26, 2026 close.
Frequently Asked Questions About Legend Biotech
What is the current stock price for LEGN?
As of the Oct 26, 2026 close, LEGN stock trades at $20.39. The 52-week range is $16.24–$37.50, with a day range of $19.08–$21.04.
What is the P/E ratio for LEGN?
The P/E ratio (Price-to-Earnings) for LEGN is shown in the Key Statistics section. This valuation metric helps compare Legend Biotech Corporation to industry peers.
Does LEGN pay dividends?
Legend Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LEGN?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for LEGN is Buy. The average 12-month price target is $44.01, a 115.8% upside from the Oct 26, 2026 close of $20.39.
What is the market cap of LEGN?
As of the Oct 26, 2026 close, Legend Biotech's market capitalization is $3.95B, classifying it as a mid-cap company. Legend Biotech operates in the Healthcare sector within the Biotechnology industry.